155 related articles for article (PubMed ID: 17804497)
1. Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.
Pandey KK; Bera S; Zahm J; Vora A; Stillmock K; Hazuda D; Grandgenett DP
J Virol; 2007 Nov; 81(22):12189-99. PubMed ID: 17804497
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance.
Zahm JA; Bera S; Pandey KK; Vora A; Stillmock K; Hazuda D; Grandgenett DP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3358-68. PubMed ID: 18591263
[TBL] [Abstract][Full Text] [Related]
3. Molecular Interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration.
Bera S; Pandey KK; Vora AC; Grandgenett DP
J Mol Biol; 2009 May; 389(1):183-98. PubMed ID: 19362096
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 integrase strand transfer inhibitors stabilize an integrase-single blunt-ended DNA complex.
Bera S; Pandey KK; Vora AC; Grandgenett DP
J Mol Biol; 2011 Jul; 410(5):831-46. PubMed ID: 21295584
[TBL] [Abstract][Full Text] [Related]
5. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
Sinha S; Grandgenett DP
J Virol; 2005 Jul; 79(13):8208-16. PubMed ID: 15956566
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Integrase Strand Transfer Inhibitors: Novel Insights into their Mechanism of Action.
Pandey KK; Grandgenett DP
Retrovirology (Auckl); 2008 Nov; 2():11-16. PubMed ID: 19915684
[TBL] [Abstract][Full Text] [Related]
8. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.
Sinha S; Pursley MH; Grandgenett DP
J Virol; 2002 Apr; 76(7):3105-13. PubMed ID: 11884535
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration.
Pandey KK; Sinha S; Grandgenett DP
J Virol; 2007 Apr; 81(8):3969-79. PubMed ID: 17267486
[TBL] [Abstract][Full Text] [Related]
10. Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase.
Bera S; Pandey KK; Aihara H; Grandgenett DP
J Biol Chem; 2018 Oct; 293(42):16440-16452. PubMed ID: 30185621
[TBL] [Abstract][Full Text] [Related]
11. Biochemical screening assays to identify HIV-1 integrase inhibitors.
Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
[TBL] [Abstract][Full Text] [Related]
12. Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.
Pandey KK; Bera S; Vora AC; Grandgenett DP
Biochemistry; 2010 Sep; 49(38):8376-87. PubMed ID: 20799722
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.
Chen H; Engelman A
J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.
Pandey KK; Bera S; Grandgenett DP
Biochemistry; 2011 Nov; 50(45):9788-96. PubMed ID: 21992419
[TBL] [Abstract][Full Text] [Related]
15. Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase.
Goodarzi G; Im GJ; Brackmann K; Grandgenett D
J Virol; 1995 Oct; 69(10):6090-7. PubMed ID: 7666512
[TBL] [Abstract][Full Text] [Related]
16. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro.
Ellison V; Brown PO
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7316-20. PubMed ID: 8041787
[TBL] [Abstract][Full Text] [Related]
17. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684
[TBL] [Abstract][Full Text] [Related]
18. Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex.
Ding J; Zhao J; Yang Z; Ma L; Mi Z; Wu Y; Guo J; Zhou J; Li X; Guo Y; Peng Z; Wei T; Yu H; Zhang L; Ge M; Cen S
Viruses; 2017 May; 9(5):. PubMed ID: 28489061
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
Terrazas-Aranda K; Van Herrewege Y; Hazuda D; Lewi P; Costi R; Di Santo R; Cara A; Vanham G
Antimicrob Agents Chemother; 2008 Jul; 52(7):2544-54. PubMed ID: 18474579
[TBL] [Abstract][Full Text] [Related]
20. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]